Canadian Cancer Trials Group Bulletins


Mark Your Calendar - TAT 2017

15th International Congress on Targeted Anticancer Therapies (TAT)
March 6-8, 2017
Marriott Rive Gauche Hotel & Conference Centre
Paris, France

The TAT Congress is a leading meeting on innovative cancer therapeutics in the early phases of clinical development, translational research and drug development methodology. Early-phase clinical studies of promising molecularly targeted and immunological agents are presented, some for the first time ever, and discussed in a program designed and run by the world's leading oncology phase 1 investigators.

Annual TAT Congresses are the place where the world's leaders - from academia and industry - in early-phase development of new cancer therapeutics, gather annually to exchange views, discuss matters of common interest, and establish new collaborations. And they are a place where young
investigators get the opportunity to present their work to an expert audience.

For more information about this conference, please use this link ...